Arzeda, The Protein Design Company™, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. 


ARPA-E

National Science Foundation

Washington Research Foundation

Sustainable Conversion Ventures

Bioeconomy Capital

OS Fund

Conversion Ventures LLC

Universal Materials Incubator

Casdin Capital

Lewis & Clark AgriFood

Bunge Ventures

Circulate Capital

Conti Ventures

Arzeda

We are excited to be in San Francisco for #JPM2024! Arzeda is looking forward to meeting with our colleagues, partners, and future collaborators.
 
If your company is developing protein-based therapeutics, reach out to our CEO Alexandre Zanghellini  or CBO Ken Barrett to connect at JPM and learn how Arzeda is supercharging therapeutic development through AI-driven protein design.
 
alexandre.zanghellini@arzeda.com
ken.barrett@arzeda.com
issa.benna@arzeda.com

Thank you Heather Clancy  at GreenBiz Group for connecting with Arzeda CEO Alexandre Zanghellini  and Unilever's head of biotech Neil Parry to discuss all the latest innovations we have helped make possible to drive towards a more #sustainable future! Learn all about how we worked with Unilever to identify new #enzymes that can potentially cut ingredients in half in cleaning and laundry products at: https://lnkd.in/euA-Sxp3

Arzeda Chief Business Officer Ken Barrett will be speaking at this year's Alternative Fuels & Chemicals Coalition Conference in Washington D.C. at Track 3, Session 6 on Tuesday, Nov. 14 at 3:30pm EST! He will be discussing the pressing need for #renewablechemicals in the face of climate change and increased plastic pollution, and illustrating how Arzeda's Intelligent Protein Design Technology™ is transforming the way we create these #biobasedmaterials through the power of #AI. Be sure to join his talk to learn all about our technology and how we are driving the industry toward a cleaner and more sustainable future.
 
Learn more: https://lnkd.in/ey-9ETC6 


OpenFold AI Research Consortium has announced the funding of new large-scale protein studies at Professor Gabriel Rocklin's laboratory at Northwestern University! As founding members of the consortium, we are so excited to see how these datasets will further improve #proteindesign. 

Read more: https://lnkd.in/gAfguUAb

Synthetic biology is breaking barriers and bolstering innovation in industries like pharmaceuticals, food science, and agriculture through #proteindesign! Arzeda co-founders Alexandre Zanghellini and David Baker caught up with Steve Rosenbush to discuss how #AI is bringing synthetic biology to commercial markets with the advent of our Intelligent Protein Design Technology™. 

Read the full The Wall Street Journal article at: https://lnkd.in/eUUfvuHm!

U.S. Server Location

Microsoft

Microsoft Azure

Level 3 Communications

Microsoft Azure US West Region

Alexandre Zanghellini

Sales and Support

Ken Barrett

Sanjay Pal

Vice President Strategic Projects

Daniela Grabs

SVP of Business Development, Food Ingredients

Scott Fabro

Director of Assay Development

Cara Tracewell

Director, Protein Design

Jacob Bale

Business Management

Marthah De Lorme

Senior Director, DSP

Puvin Pichai

Yanniv Dorone

Mark Breier

Jonathan Dordick

Nanda Kumar

Jim Flatt

Doug Cameron

Edward Rubin

Bill Baum

President & CEO

Co-Founder & VP of Strategic Projects

Chief Financial Officer

United States Companies With Less Than $1B in Revenue (Top 10K)

Western US Companies With Fewer Than 100 Employees (Top 10K)

Companies With Less Than $500M in Revenue (Top 10K)

Washington Companies With More Than 50 Employees

Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals. The company provides intelligent protein design technology, combining physics-based protein design and AI algorithms to develop, validate, and manufacture new designer proteins and enzymes.

Fall Line Capital

Silver Blue

Sofinnova Partners

Sucden Ventures

W.L. Gore & Associates

Series C - Arzeda

Series B - Arzeda

Venture Round - Arzeda

Series A - Arzeda

Grant - Arzeda

Seattle

Washington

United States

North America

The Week in AgriFoodTech: eGrocer Flink nabs $150m, biotech co Arzeda lands $38m, Kubota acquires Bloomfield Robotics

Arzeda Closes $38M Funding Round

Arzeda Raises $38M to Accelerate Protein Design Commercialization

Arzeda Partnership Looks to Revolutionize the Future of Designer Proteins

Compositions and methods for producing rebaudioside m

Compositions and methods for producing rebaudioside d

Arzeda Is Synthesizing A Sweeter And Healthier World, One Engineered Enzyme At A Time

Automated method of computational enzyme identification and design

Industry Leading Protein Design Company, Arzeda, Expands Leadership Team with Addition of Ken Barrett and Scott Fabro

Enzymes developed for efficient production of Reb D and Reb M from stevia leaf extract, enhancing sweetness and purity.

A technology platform combining computational design and AI to create novel proteins and enzymes.

Collaboration focused on developing enzymes for sustainable and high-performance cleaning and laundry products.

Joint development agreement to innovate in materials science with sustainable and performance-enhancing proteins.

Collaboration using AI-based protein design to optimize protein biologics for therapeutic products.

Joint development agreement to innovate plant-based oils for the food industry through novel enzymes.

India

Asia

Indonesia

HTML5

Lightbox

Bootstrap

Microsoft Outlook

GreenSock Animation Platform

Wordpress

Vimeo

jQuery

Apache Server

Google Tag Manager

Cradle focuses on the intersection of biology and artificial intelligence.

Cradle

Primrose Bio

Ginkgo Bioworks operates in the field of biotechnology and synthetic biology.

Ginkgo Bioworks

Rooted Leaf Agritech

Cerevast Medical

Confidence Analytics

Codexis

Biocatalysts

Novozymes operates as a biotechnology-based company. It researches, develops, and produces industrial enzymes, microorganisms, and biopharmaceutical ingredients.

Novozymes

Evolva

Arzeda is a biotechnology company that specializes in the development of novel enzymes and chemical products through the use of proprietary advanced computational and synthetic biology technologies. The company's mission is to create sustainable solutions for a variety of industries, including pharmaceuticals, agriculture, and chemicals.

news impact assignment basic	general
public peers	general	May 15, 2024 11:59 AM	ad2d9f38
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	457a920c
crunchbase profile	general	Nov 22, 2024 9:29 AM	4e0226d8
li profile	general	May 15, 2024 11:59 AM	8c75e95a
translate crunchbase fundingrounds	general	Nov 22, 2024 2:02 PM	ed0ceb2c
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ARZEDA

Arzeda